Compound Detail
CHEMBL3585866
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL3585866 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | OJRXRGXLOGKLJB-UHFFFAOYSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
7
Publications
0
Known Names
Molecular Properties
299.4
MW (Da)
2.97
ALogP
4
HBA
3
HBD
82.7
PSA (Ų)
0.70
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 6.37
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HCT-116 | IC50 | = | 430.0 | nM | 6.37 | Cytotoxicity against human HCT116 cells assessed as inhibition of cell prolifera... | 25936258 |
| HepG2 | IC50 | = | 790.0 | nM | 6.1 | Cytotoxicity against human HepG2 cells assessed as inhibition of cell proliferat... | 25936258 |
| A549 | IC50 | = | 1020.0 | nM | 5.99 | Cytotoxicity against human A549 cells assessed as inhibition of cell proliferati... | 25936258 |
| HUVEC | IC50 | = | 1230.0 | nM | 5.91 | Cytotoxicity against HUVEC assessed as inhibition of cell proliferation rate aft... | 25936258 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 25936258 | 10.1016/j.bmc.2015.03.085 | HUVEC | 4 |
| 25936258 | 10.1016/j.bmc.2015.03.085 | HCT-116 | 1 |
| 25936258 | 10.1016/j.bmc.2015.03.085 | HepG2 | 1 |
| 25936258 | 10.1016/j.bmc.2015.03.085 | A549 | 1 |
| 25936258 | 10.1016/j.bmc.2015.03.085 | Thoracic aorta | 1 |
| 25936258 | 10.1016/j.bmc.2015.03.085 | Unchecked | 1 |
| 25936258 | 10.1016/j.bmc.2015.03.085 | Tubulin | 1 |
Data from ChEMBL 36 via Core Engine